Cassava Sciences (SAVA) Short Interest Ratio & Short Volume $2.19 +0.07 (+3.30%) Closing price 06/6/2025 04:00 PM EasternExtended Trading$2.19 +0.00 (+0.23%) As of 06/6/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cassava Sciences Short Interest DataCassava Sciences (SAVA) has a short interest of 10.03 million shares, representing 22.91% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 3.02 million shares to cover all short positions.Current Short Interest10,030,000 sharesPrevious Short Interest10,030,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$20.56 millionShort Interest Ratio6.3 Days to CoverLast Record DateMay 15, 2025Outstanding Shares48,308,000 sharesShort Percent of Float22.91%Today's Trading Volume1,063,224 sharesAverage Trading Volume3,015,036 sharesToday's Volume Vs. Average35% Short Selling Cassava Sciences? Sign up to receive the latest short interest report for Cassava Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSAVA Short Interest Over TimeSAVA Days to Cover Over TimeSAVA Percentage of Float Shorted Over Time Cassava Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202510,030,000 shares $20.56 million No Change22.9%6.3 $2.05 4/30/202510,030,000 shares $15.65 million -9.6%N/A6.5 $1.56 4/15/202511,090,000 shares $15.86 million -0.5%25.3%6.8 $1.43 3/31/202511,150,000 shares $16.73 million -6.1%25.5%5.9 $1.50 3/15/202511,880,000 shares $33.15 million -17.8%27.1%5.2 $2.79 2/28/202514,450,000 shares $34.68 million -9.4%33.0%5.6 $2.40 2/15/202515,940,000 shares $38.57 million +0.6%36.4%3 $2.42 1/31/202515,850,000 shares $37.72 million +3.2%N/A2.9 $2.38 1/15/202515,360,000 shares $41.63 million -7.6%N/A2.8 $2.71 12/31/202416,630,000 shares $39.25 million -5.6%N/A3 $2.36 Get the Latest News and Ratings for SAVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/202417,620,000 shares $48.46 million +2.7%N/A3.4 $2.75 11/30/202417,160,000 shares $65.89 million -5.1%N/A3.5 $3.84 11/15/202418,080,000 shares $486.53 million -2.6%N/A4.9 $26.91 10/31/202418,570,000 shares $479.20 million -2.0%N/A10.7 $25.81 10/15/202418,940,000 shares $535.24 million +7.4%N/A7.2 $28.26 9/30/202417,630,000 shares $518.85 million +10.8%N/A5.6 $29.43 9/15/202415,910,000 shares $447.39 million +0.6%N/A4.6 $28.12 8/31/202415,810,000 shares $453.91 million -10.6%N/A4.9 $28.71 8/15/202417,680,000 shares $501.94 million -7.1%N/A5.6 $28.39 7/31/202419,030,000 shares $422.85 million +18.0%N/A6.5 $22.22 7/15/202416,130,000 shares $198.88 million +23.2%N/A8.3 $12.33 6/30/202413,090,000 shares $161.66 million +3.5%N/A9 $12.35 6/15/202412,650,000 shares $249.46 million +1.7%N/A15.7 $19.72 5/31/202412,440,000 shares $274.05 million -2.8%N/A15 $22.03 5/15/202412,800,000 shares $294.53 million -7.7%N/A15.4 $23.01 4/30/202413,870,000 shares $307.22 million +8.0%N/A17.4 $22.15 4/15/202412,840,000 shares $256.93 million +8.9%N/A17.7 $20.01 3/31/202411,790,000 shares $239.22 million -1.4%N/A17 $20.29 3/15/202411,960,000 shares $254.63 million +5.7%30.5%15.7 $21.29 2/29/202411,320,000 shares $260.13 million -3.7%28.9%11.4 $22.98 2/15/202411,760,000 shares $288.94 million -3.5%30.7%12.3 $24.57 1/31/202412,180,000 shares $291.71 million -8.6%31.8%11.5 $23.95 1/15/202413,330,000 shares $349.78 million -4.0%33.6%10.2 $26.24 12/31/202313,890,000 shares $312.66 million +8.9%35.0%9.2 $22.51 12/15/202312,760,000 shares $268.96 million -7.0%32.2%8.6 $21.08 11/30/202313,720,000 shares $285.79 million -5.8%34.7%11.2 $20.83 11/15/202314,560,000 shares $317.70 million -8.9%36.8%11.3 $21.82 10/31/202315,990,000 shares $322.20 million +14.1%40.6%12.4 $20.15 10/15/202314,020,000 shares $208.34 million -1.3%35.6%13.1 $14.86 9/30/202314,210,000 shares $236.45 million +3.7%36.1%17.2 $16.64The DOJ Just Paved the Way for Account Seizures (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >> 9/15/202313,700,000 shares $265.92 million +2.7%34.8%14.8 $19.41 8/31/202313,340,000 shares $279.74 million +8.8%33.9%14.8 $20.97 8/15/202312,260,000 shares $215.16 million +7.3%31.1%14.9 $17.55 7/31/202311,430,000 shares $251.23 million +2.1%29.0%13.4 $21.98 7/15/202311,200,000 shares $242.26 million +10.5%28.6%13.9 $21.63 6/30/202310,140,000 shares $248.63 million +8.1%25.9%13 $24.52 6/15/20239,380,000 shares $235.16 million -13.2%23.9%14.4 $25.07 5/31/202310,800,000 shares $245.27 million +6.3%27.6%15.2 $22.71 5/15/202310,160,000 shares $269.34 million -7.5%25.9%14.4 $26.51 4/30/202310,980,000 shares $254.96 million -0.6%28.0%14.5 $23.22 4/15/202311,050,000 shares $257.69 million -3.9%28.2%10.1 $23.32 3/31/202311,500,000 shares $277.38 million +9.9%30.0%9.7 $24.12 3/15/202310,460,000 shares $272.48 million -5.0%27.3%7.9 $26.05 2/28/202311,010,000 shares $271.95 million +3.9%28.7%7.9 $24.70 2/15/202310,600,000 shares $279.95 million +7.6%27.6%7.6 $26.41 1/31/20239,850,000 shares $275.80 million -4.6%25.1%6.4 $28.00 1/15/202310,320,000 shares $350.88 million +18.8%26.3%7.3 $34.00 12/30/20228,690,000 shares $256.70 million -1.3%22.1%7 $29.54 12/15/20228,800,000 shares $348.22 million -5.7%22.4%5.6 $39.57 11/30/20229,330,000 shares $324.96 million No Change23.8%4 $34.83 11/15/20229,330,000 shares $374.13 million -0.4%23.8%3.7 $40.10 10/31/20229,370,000 shares $341.44 million -2.7%24.9%2.8 $36.44 10/15/20229,630,000 shares $351.11 million -10.7%25.6%2.6 $36.46 9/30/202210,780,000 shares $450.82 million -14.1%N/A2.9 $41.82 9/15/202212,550,000 shares $396.33 million -0.2%N/A3.7 $31.58 8/31/202212,580,000 shares $323.68 million +4.4%N/A5.1 $25.73 8/15/202212,050,000 shares $243.29 million +5.4%N/A5.1 $20.19 7/31/202211,430,000 shares $186.65 million +12.3%N/A7.7 $16.33 7/15/202210,180,000 shares $243.40 million -2.2%N/A8.4 $23.91 6/30/202210,410,000 shares $292.73 million -5.1%N/A7.1 $28.12 6/15/202210,970,000 shares $294.00 million -4.9%N/A6.7 $26.80 5/31/202211,530,000 shares $352.82 million -2.7%30.9%7 $30.60 5/15/202211,850,000 shares $227.99 million +0.9%31.8%7.5 $19.24 4/30/202211,750,000 shares $245.22 million +2.5%31.5%6.9 $20.87 4/15/202211,460,000 shares $300.83 million +7.4%31.5%6.5 $26.25 3/31/202210,670,000 shares $396.28 million -2.4%29.4%6.4 $37.14 3/15/202210,930,000 shares $380.91 million -3.3%30.1%5.1 $34.85 2/28/202211,300,000 shares $480.36 million -5.4%31.1%4.7 $42.51 2/15/202211,950,000 shares $588.18 million -12.1%32.9%4.7 $49.22 1/31/202213,600,000 shares $601.80 million +4.7%37.4%4.4 $44.25 1/15/202212,990,000 shares $595.98 million -4.6%34.8%2.8 $45.88 12/31/202113,610,000 shares $594.76 million +11.7%36.5%2.8 $43.70 12/15/202112,190,000 shares $558.06 million +18.9%N/A2.2 $45.78 11/30/202110,250,000 shares $548.27 million +22.3%27.5%1.7 $53.49 11/15/20218,380,000 shares $507.07 million -26.2%22.5%1 $60.51 10/29/202111,350,000 shares $489.53 million +20.5%30.4%1.3 $43.13 10/15/20219,420,000 shares $468.08 million +7.4%25.3%1.2 $49.69 9/30/20218,770,000 shares $544.44 million -1.2%23.5%1.1 $62.08 9/15/20218,880,000 shares $390.01 million +12.4%23.8%1.1 $43.92 8/31/20217,900,000 shares $449.12 million +46.3%21.2%1.1 $56.85Your Bank Account Is No Longer Safe (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 8/13/20215,400,000 shares $661.88 million +35.0%14.5%1.3 $122.57 7/30/20214,000,000 shares $278.12 million -9.5%10.7%1 $69.53 7/15/20214,420,000 shares $364.34 million +11.6%11.9%1.7 $82.43 6/30/20213,960,000 shares $338.34 million +5.3%10.6%1.8 $85.44 6/15/20213,760,000 shares $271.10 million -0.5%10.1%2 $72.10 5/28/20213,780,000 shares $203.82 million +8.9%10.1%2.1 $53.92 5/14/20213,470,000 shares $131.10 million -7.7%N/A1.9 $37.78 4/30/20213,760,000 shares $178.86 million +3.6%N/A1.2 $47.57 4/15/20213,630,000 shares $129.48 million +5.5%N/A0.6 $35.67 3/31/20213,440,000 shares $151.22 million -5.8%N/A0.5 $43.96 3/15/20213,650,000 shares $195.06 million +24.2%N/A0.5 $53.44 2/26/20212,940,000 shares $149.59 million +12.2%N/A0.4 $50.88 2/12/20212,620,000 shares $126.26 million -56.2%N/A0.4 $48.19 1/29/20215,980,000 shares $111.95 million +9.5%N/A1 $18.72 1/15/20215,460,000 shares $57.22 million +2.1%N/A1.6 $10.48 12/31/20205,350,000 shares $37.50 million +2.9%N/A2 $7.01 12/15/20205,200,000 shares $40.35 million -12.9%N/A1.7 $7.76 11/30/20205,970,000 shares $46.33 million -0.3%N/A0.7 $7.76 11/15/20205,990,000 shares $50.14 million +11.8%N/A0.7 $8.37 10/30/20205,360,000 shares $46.79 million +15.5%N/A0.7 $8.73 10/15/20204,640,000 shares $50.99 million -6.8%N/A0.7 $10.99 9/30/20204,980,000 shares $57.32 million +79.1%N/A0.7 $11.51 9/15/20202,780,000 shares $19.52 million -8.0%N/A0.4 $7.02 8/31/20203,020,000 shares $9.48 million +4.5%N/A1.7 $3.14 8/14/20202,890,000 shares $9.77 million -7.1%N/A0.9 $3.38 7/31/20203,110,000 shares $9.86 million -11.1%N/A0.7 $3.17 7/15/20203,500,000 shares $12.78 million +3.2%N/A0.8 $3.65 6/30/20203,390,000 shares $10.44 million +19.4%N/A0.8 $3.08 6/15/20202,840,000 shares $7.30 million -4.4%N/A0.8 $2.57 SAVA Short Interest - Frequently Asked Questions What is Cassava Sciences' current short interest? Short interest is the volume of Cassava Sciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 10,030,000 shares of SAVA short. 22.91% of Cassava Sciences' shares are currently sold short. Learn More on Cassava Sciences' current short interest. What is a good short interest ratio for Cassava Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAVA shares currently have a short interest ratio of 6.0. Learn More on Cassava Sciences's short interest ratio. Which institutional investors are shorting Cassava Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cassava Sciences: Jane Street Group LLC, Affinity Asset Advisors LLC, Walleye Trading LLC, Atika Capital Management LLC, Persistent Asset Partners Ltd, Simplex Trading LLC, National Bank of Canada FI, Belvedere Trading LLC, and Jefferies Financial Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cassava Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.91% of Cassava Sciences' floating shares are currently sold short. How does Cassava Sciences' short interest compare to its competitors? 22.91% of Cassava Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cassava Sciences: COMPASS Pathways plc (7.78%), Humacyte, Inc. (24.14%), Mereo BioPharma Group plc (5.34%), Erasca, Inc. (13.07%), ABIVAX Société Anonyme (2.12%), Benitec Biopharma Inc. (1.90%), Kamada Ltd. (0.10%), Precigen, Inc. (17.75%), iTeos Therapeutics, Inc. (8.57%), Revance Therapeutics, Inc. (4.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Cassava Sciences stock? Short selling SAVA is an investing strategy that aims to generate trading profit from Cassava Sciences as its price is falling. SAVA shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cassava Sciences? A short squeeze for Cassava Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SAVA, which in turn drives the price of the stock up even further. How often is Cassava Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAVA, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies COMPASS Pathways Short Interest Data Humacyte Short Interest Data Mereo BioPharma Group Short Interest Data Erasca Short Interest Data ABIVAX Société Anonyme Short Interest Data Benitec Biopharma Short Interest Data Kamada Short Interest Data Precigen Short Interest Data iTeos Therapeutics Short Interest Data Revance Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SAVA) was last updated on 6/7/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAVA Stock Free SAVA Stock Alerts